| 询价 | |
| V01303-1 | |
|
|
|
|
|
|
|
|
|
| Specificity | Human CK-MB |
| Recommended Pairs |
ELISA/TRFIA (Capture-Detection): 8D8 - 2F1 ELISA/CLIA (Capture-Detection): 8D8 - 1F7 |
| Clone ID | 2F1 |
| Isotype | Mouse IgG1 for Mabs 2F1 |
| Subclass | IgG1 |
| Host Species | Mouse |
| Antigen Species | Human |
| Conjugation | Unconjugated |
| Production | Cultured in vitro under conditions free from animal-derived components |
| Purification | Protein A/G affinity column |
| Concentration | ≥ 2mg/ml |
| Formulation | 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300. |
| Storage | For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles. |
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. |
|
|||||||||||||||||
»
| Target Background | Creatine kinase (CK) is a dimeric enzyme, including three isoforms of creatine kinase: BB, MM, and MB. Level of serum CK-MB will be increased within 4-6 hours after a myocardial infarction (MI). CK-MB is considered as a useful marker for the diagnosis of myocardial infarction. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
